The article presents the world data on the incidence, clinical picture and diagnosis of solid pseudopapillary neoplasm both in general and in pregnant women. Two clinical cases of solid pseudopapillary neoplasm in pregnant women were described in detail, with highly specialized surgical and perinatal care in the hospitals of the Center for Surgery of Liver, Biliary and Pancreatic Diseases n.V.S.Zemskov (surgical department) and in the department of surgical gynecology of the SI «Institute of pediatrics, obstetrics and gynecology National Academy of Medical Sciences of Ukraine». Demonstrate the features of diagnosis, surgical treatment of patients with solid pseudopapillary neoplasms during pregnancy. Key words: solid pseudopapillary neoplasm, surgical treatment, pregnancy, management of pregnancy and childbirth.
Peritoneal pseudomixome (PMP) is a rare clinical condition characterized by a localized or generalized accumulation of gelatin-like content, associated in most cases with mucinous tumors of the digestive tract, and more rarely ovaries. Based on the presentation of the clinical case of MBP caused by ovarian border neoplasia, the effect of cytoreduction on the further course of the disease as an independent treatment method was analyzed. The clinical case presented in this article reflects a rare combination of borderline ovarian tumor with PMP. The effectiveness of performing cytoreductive surgery has been proved, which calls into question the advisability of chemotherapy in patients with tumors of a potentially low degree of malignancy. Key words: borderline mucinous cystadenoma, pseudomyxoma peritonei, debulking.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.